Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: The subsequent phases of thyroid function in a patient chronically treated with amiodarone

R. Minelli, E. Gardini, L. Bianconi, M. Salvi, Elio Roti

Research output: Contribution to journalArticle

Abstract

In a patient chronically treated with amiodarone, subclinical iodine-induced hypothyroidism occurred as a result of excess iodine released from the amiodarone molecule. The patient was maintained on amiodarone and developed thyrotoxicosis as a result of a destructive process into the thyroid follicles. Amiodarone was withdrawn and methylprednisolone and methimazole treatment was started with resolution of the thyrotoxic phase. Months later, off therapy, the patient developed subclinical hypothyroidism. This is the first description of hypo-and hyperthyroidism in the same patient caused by amiodarone therapy. This unusual observation suggests that patients treated with amiodarone are at risk to develop hyperthyroidism even if they show laboratory findings consistent with hypothyroidism.

Original languageEnglish
Pages (from-to)853-855
Number of pages3
JournalJournal of Endocrinological Investigation
Volume15
Issue number11
DOIs
Publication statusPublished - 1992

Fingerprint

Thyrotoxicosis
Amiodarone
Hypothyroidism
Thyroid Gland
Hyperthyroidism
Iodine
Methimazole
Methylprednisolone
Therapeutics
Observation

Keywords

  • Amiodarone
  • hypothyroidism
  • thyrotoxicosis

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

@article{58df65d4283445639fe71e518458dd33,
title = "Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: The subsequent phases of thyroid function in a patient chronically treated with amiodarone",
abstract = "In a patient chronically treated with amiodarone, subclinical iodine-induced hypothyroidism occurred as a result of excess iodine released from the amiodarone molecule. The patient was maintained on amiodarone and developed thyrotoxicosis as a result of a destructive process into the thyroid follicles. Amiodarone was withdrawn and methylprednisolone and methimazole treatment was started with resolution of the thyrotoxic phase. Months later, off therapy, the patient developed subclinical hypothyroidism. This is the first description of hypo-and hyperthyroidism in the same patient caused by amiodarone therapy. This unusual observation suggests that patients treated with amiodarone are at risk to develop hyperthyroidism even if they show laboratory findings consistent with hypothyroidism.",
keywords = "Amiodarone, hypothyroidism, thyrotoxicosis",
author = "R. Minelli and E. Gardini and L. Bianconi and M. Salvi and Elio Roti",
year = "1992",
doi = "10.1007/BF03348819",
language = "English",
volume = "15",
pages = "853--855",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "11",

}

TY - JOUR

T1 - Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism

T2 - The subsequent phases of thyroid function in a patient chronically treated with amiodarone

AU - Minelli, R.

AU - Gardini, E.

AU - Bianconi, L.

AU - Salvi, M.

AU - Roti, Elio

PY - 1992

Y1 - 1992

N2 - In a patient chronically treated with amiodarone, subclinical iodine-induced hypothyroidism occurred as a result of excess iodine released from the amiodarone molecule. The patient was maintained on amiodarone and developed thyrotoxicosis as a result of a destructive process into the thyroid follicles. Amiodarone was withdrawn and methylprednisolone and methimazole treatment was started with resolution of the thyrotoxic phase. Months later, off therapy, the patient developed subclinical hypothyroidism. This is the first description of hypo-and hyperthyroidism in the same patient caused by amiodarone therapy. This unusual observation suggests that patients treated with amiodarone are at risk to develop hyperthyroidism even if they show laboratory findings consistent with hypothyroidism.

AB - In a patient chronically treated with amiodarone, subclinical iodine-induced hypothyroidism occurred as a result of excess iodine released from the amiodarone molecule. The patient was maintained on amiodarone and developed thyrotoxicosis as a result of a destructive process into the thyroid follicles. Amiodarone was withdrawn and methylprednisolone and methimazole treatment was started with resolution of the thyrotoxic phase. Months later, off therapy, the patient developed subclinical hypothyroidism. This is the first description of hypo-and hyperthyroidism in the same patient caused by amiodarone therapy. This unusual observation suggests that patients treated with amiodarone are at risk to develop hyperthyroidism even if they show laboratory findings consistent with hypothyroidism.

KW - Amiodarone

KW - hypothyroidism

KW - thyrotoxicosis

UR - http://www.scopus.com/inward/record.url?scp=0027008727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027008727&partnerID=8YFLogxK

U2 - 10.1007/BF03348819

DO - 10.1007/BF03348819

M3 - Article

C2 - 1291598

AN - SCOPUS:0027008727

VL - 15

SP - 853

EP - 855

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 11

ER -